Industry knowledge · 16 November 2026 · Stefan Bensmo

Nicotine pouches and oral health in 2026: what the evidence says about gums, lesions and teeth

Short answer: Research shows that nicotine pouches can cause local changes where the pouch rests, including redness, irritation and ulcers. But studies remain few, often small or short, and cannot establish long-term risks for periodontal disease, cancer or other conditions. “Tobacco-free” does not mean risk-free – but oral findings should not be conflated with the total health risk of cigarette smoking.

Editorial illustration of research and product analysis
Editorial illustration. It does not depict actual patients or products.

What the largest clinical comparison found

A Swedish study by Karolinska Institutet and Public Dental Services Stockholm examined 126 tobacco-free nicotine pouch users, 63 tobacco snus users and 83 non-users. Oral lesions were recorded in 79% of pouch users and 89% of snus users. Pouch users more often showed redness and reported symptoms, while thickened mucosa was more common among snus users (Oral Diseases study; Karolinska Institutet).

The study did not find more caries or periodontal disease during up to six years of use. That is not proof of long-term safety: a cross-sectional study observes associations at one point and cannot establish future risk.

Why another study found improvement

A four-week randomized study followed 45 daily snus users who switched to two ZYN formulations. Existing snus lesions became less severe and most inflammatory markers did not change materially (Clinical Oral Investigations). This need not contradict the larger comparison. One study asks how pouch users differ from other groups; the other asks what happens when people with existing snus lesions switch products for 28 days.

What the evidence can – and cannot – establish

EvidenceSignalLimitation
Swedish comparison, 272 peopleRedness, symptoms and local lesionsCross-sectional; cannot establish cause or long-term risk
Snus-switch study, 45 peopleLess severe existing snus lesionsFour weeks and two specific products
US pilot, 26 firefightersWorse periodontal measures and microbiome shiftsVery small, hypothesis-generating sample
2024 systematic reviewLocal changes recur across studiesOnly three studies, all at high risk of bias

The US pilot included only twelve users and fourteen non-users and requires caution (periodontal pilot study). The 2024 systematic review found only three relevant studies and judged all to carry substantial methodological uncertainty (systematic review).

Nicotine, flavour and physical contact

A pouch remains against one small area for an extended period. Reactions may depend on nicotine, pH, moisture, flavourings, fillers, contact time and repeated placement. The UK Committee on Toxicity identifies prolonged local exposure to flavourings and other ingredients as a major evidence gap and notes that systemic nicotine exposure can reach cigarette-like levels (COT). Germany's BfR has found that high-dose products may produce nicotine levels above cigarettes (BfR).

Our assessment

The best-supported finding in 2026 is local mucosal impact. How formulation, strength and duration influence long-term risk remains poorly established. Product developers should not reduce tolerability to milligrams per pouch: irritation, pH, moisture and flavour systems require product testing and post-market monitoring.

Practical conclusions

Method and scope: This review uses published studies and authority assessments checked on 16 November 2026. It is not individual medical or dental advice.

Need to assess a market, product or regulatory risk?

Book an initial call